(1) Analysis of 156 records relating to patients at the age of 15 to 85 years with extended purulent peritonitis of the surgical and gynecological genesis (the toxic phase, VI category ASA) showed that combination of programmed sanitation laparotomy and intensive antibacterial therapy performed as short-term courses before, during and after the operation with an account of the information on the nature of the microbial associations and antibioticograms was an efficient procedure in treatment of severe peritonitis.
(2) It is assumed that the mild analgesia produced by acetylsalicylic acid (ASA) and indomethacin is due to a common mode of action, namely inhibition of the cyclo-oxygenase reaction in the synthesis of prostaglandins.
(3) Since ASA has a greater potential for adverse effects, paracetamol is increasingly preferred to ASA, particularly in children.
(4) ASA was given as 7.5 or 15.0 mM solution in 100 mM hydrochloric acid or in 100 mM sodium chloride.
(5) Although no 14C-serotonin secretion occurred in presence of acetylsalicyclic acid (ASA), microbubble-induced platelet aggregation was only marginally reduced.
(6) A haemodynamic study was performed in 74 unpremedicated children (ASA I; aged 0-2 yr (n = 15), 2-8 yr (n = 26) and older than 8 yr (n = 35).
(7) An identification program named ASA was developed for this purpose.
(8) The 4-azidosalicylate derivative of 1,3-bis(D-mannos-4'-yloxy)-2-[2-3H]propylamine (ASA-[2-3H]BMPA) has been tested as a photoaffinity label for the sugar transporter in human erythrocytes.
(9) Significant bronchoconstriction to open challenges with agents other than ASA was less frequent.
(10) Urine from normal children showed a small acid-labile (at 100 degrees C) peak at the ASA position, which we tentatively assign to genuine ASA.
(11) There were no significant differences between the two groups in age, sex distribution, ASA class and performance in the tests, both before and after surgery.
(12) It is presently unknown to what extent the treatment with acetylsalicylic acid (ASA) inhibits platelet PAI-1 release and if release inhibition has an effect on plasma PAI-1 levels.
(13) Intra- and extracellular 5-ASA and Ac-ASA were measured by high performance liquid chromatography.
(14) After liberation of 5-ASA in the terminal ileum (only slow release oral preparations of 5-ASA) and colon (5-ASA suppositories and enemas), 5-ASA is only partly absorbed.
(15) 5-Aminosalicylic acid and its metabolite, N-ac-5-ASA, were measured in the plasma, urine, and ileostomy effluent of 24 ileostomates who ingested 750 mg Rowasa I following an overnight fast.
(16) Five microliters of acetic anhydride was added to the serum to convert all 5-ASA to Ac-5-ASA.
(17) Medically unsupervised long-term ASA use for primary or secondary prevention of ischemic vascular disease was uncommon (reported by 2% of those who used the drug routinely).
(18) The purpose of this study was to characterize the pharmacodynamics and pharmacokinetics of three concentrations of the new long-acting amide local anesthetic, ropivacaine, given epidurally in 15 physical status ASA I or II patients for elective lower-extremity orthopedic procedures using a nonrandomized open-label design.
(19) In asthmatic patients with aspirin sensitivity, who undergo ASA desensitization, continuous treatment with ASA or NSAIDs is realistic.
(20) Metoprolol kinetics remained uninfluenced whereas the maximal plasma concentrations of the salicylates were significantly higher than in the ASA control period.
Be
Definition:
(v. i.) To exist actually, or in the world of fact; to have ex/stence.
(v. i.) To exist in a certain manner or relation, -- whether as a reality or as a product of thought; to exist as the subject of a certain predicate, that is, as having a certain attribute, or as belonging to a certain sort, or as identical with what is specified, -- a word or words for the predicate being annexed; as, to be happy; to be here; to be large, or strong; to be an animal; to be a hero; to be a nonentity; three and two are five; annihilation is the cessation of existence; that is the man.
(v. i.) To take place; to happen; as, the meeting was on Thursday.
(v. i.) To signify; to represent or symbolize; to answer to.